UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Total revenue	$ 797.4	$ 800.7	$ 1,598.8	$ 1,522.4
Total cost of revenue	439.5	416.1	849.7	785.0
Gross profit	357.9	384.6	749.1	737.4
Operating expenses:
Selling, general and administrative	231.4	221.3	456.8	416.6
Research and development	100.2	92.2	197.3	174.0
Other charges, net	14.4	23.0	51.3	33.9
Total operating expenses	346.0	336.5	705.4	624.5
Operating income	11.9	48.1	43.7	112.9
Interest and other income (expense), net	(11.4)	(24.2)	(18.1)	(17.4)
Income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries	0.5	23.9	25.6	95.5
Income tax provision (benefit)	(3.1)	16.1	5.6	35.9
Equity in income (loss) of unconsolidated investees, net of tax	0.6	(0.2)	1.0	0.0
Consolidated net income	4.2	7.6	21.0	59.6
Net income (loss) attributable to noncontrolling interests in consolidated subsidiaries	(3.4)	0.0	(4.0)	1.1
Net income attributable to Bruker Corporation	$ 7.6	$ 7.6	$ 25.0	$ 58.5
Net income per common share attributable to Bruker Corporation shareholders:
Basic	$ 0.05	$ 0.05	$ 0.16	$ 0.4
Diluted	$ 0.05	$ 0.05	$ 0.16	$ 0.4
Weighted average common shares outstanding:
Basic	151.6	147.4	151.6	146.3
Diluted	151.7	148.0	151.8	147.0
Product
Total revenue	$ 634.7	$ 654.4	$ 1,278.0	$ 1,241.3
Total cost of revenue	346.1	326.0	668.4	617.7
Service and other revenue
Total revenue	162.7	146.3	320.8	281.1
Total cost of revenue	$ 93.4	$ 90.1	$ 181.3	$ 167.3